Familial hypocalciuric hypercalcemia secondary prevention

Familial hypocalciuric hypercalcemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Familial Hypocalciuric Hypercalcemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Familial hypocalciuric hypercalcemia secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Familial hypocalciuric hypercalcemia secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Familial hypocalciuric hypercalcemia secondary prevention
CDC on Familial hypocalciuric hypercalcemia secondary prevention
Familial hypocalciuric hypercalcemia secondary prevention in the news
Blogs on Familial hypocalciuric hypercalcemia secondary prevention
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Familial hypocalciuric hypercalcemia secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There are no established measures for the secondary prevention of FHH.

Secondary Prevention

• There are no established measures for the secondary prevention of [disease name].

OR

• Effective measures for the secondary prevention of [disease name] include:
  • [Strategy 1]
  • [Strategy 2]
  • [Strategy 3]